Navigation Links
New Clinical Trial Review: Leukemia Patients Treated by Bellicum Pharmaceuticals -- 91% remission, 94% Survival (median follow-up 301 Days) Source: Pluvia Research

April 10, 2017, a new clinical trial report released today compares the significance of historic results treating Acute Leukemia patients vs clinical trial data reported by Bellicum Pharmaceuticals (NASDAQ: BLCM). The clinical trial review was released by Pluvia Securities Research (PSR).

The report reviews data from 122 malignant and non-malignant patients treated with BPX-501 (Bellicum Pharmaceuticals, clinical trial identifier NCT01865617 & NCT02065869). Leukemia patients treated by Bellicum, (n=35) had an overall survival rate of 94% at 6 months compared to a historical 6 month leukemia survival rate of 78% (source: National Donor Marrow Program)

56 patients with non-malignant blood disorders are also treated in the Bellicum trial. These include patients with Sickle Cell disease, Thalassemia Major and Wiscott-Aldrich. The report issued by PSR compares historical survival of these diseases at 1yr (82-92%) with 100% survival of patients treated by Bellicum BPX-501.

The full PSR Clinical Trial Review of Bellicum BPX-501 is available for free download (here)

For Additional Information Contact:
Steve Pluvia
Pluvia Research

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related medicine news :

1. Allegheny Health Network Clinical Trial Examines Regorafenib as Maintenance Therapy for Colon Cancer
2. DrugDev Thought Leaders Share Experience and Insights on How Transformative Technology Improves Clinical Trials at Premier Pharma and Biotech Industry Conferences in Q2
3. Catalent Expands Kansas City Clinical Storage and Secondary Packaging Capabilities to Meet Growing Demand for Cold Chain Services
4. New DrugDev Educational Webinar Reveals How Biotechs and Smaller Pharmaceutical Companies Gain Site Attention and Engagement by Optimizing Clinical Trial Payments
5. FDAnews Announces — Medical Device Clinical Evaluation Reports: Complying with European Guidelines and the New MEDDEV 2.7/1 Rev. 4 Guidance Webinar, April 4, 2017
6. Catalent Wins Prestigious Clinical Supply Chain Excellence Award at BioPharma Asia Convention
7. Intrinsic Imaging Awarded Phase II Immuno-Oncology Clinical Trial for the Treatment of Non-Small Cell Lung Cancer and Small Cell Lung Cancer
8. Challenges and Innovation in Clinical Trial Supply to be Presented by Catalent Experts at Upcoming Conferences
9. Peanut Patch Continues to Show Promise in Extension of Latest Clinical Trial
10. New Clinical Data on Cryoablation For The Treatment Of Early Stage Breast Cancer To Be Presented At Susan G. Komen San Diego
11. ERT Clinical Trial Oversight Selected by Premier Research
Post Your Comments:
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards luncheon ... editorial and design excellence across a range of sectors. This year’s program included the ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: